
The clinical zzso of acute heart failure and the low number of controlled trials, to date, are the main causes of the lack of agreement on therapeutic zzso uncertainty on the most appropriate management, and difficulties to obtain robust evidence for the treatment of this zzso The inappropriate use of zzso agents is one the most common pitfalls shown by zzso Two to zzso of patients admitted for acute heart failure present with a low output syndrome, a clinical profile associated with high zzso where zzso may be a rational therapeutic zzso zzso points for an effective use of zzso are an accurate evaluation and selection of patients, tailoring of therapeutic schemes and strict patient zzso zzso zzso and zzso zzso increase zzso oxygen demand, favor zzso and may cause peripheral zzso with a secondary decrease in coronary zzso zzso These effects may translate in zzso zzso loss of zzso and accelerated zzso zzso with worse zzso zzso a novel zzso agent studied according to the principles of evidence-based medicine, zzso zzso zzso without changes in zzso calcium zzso and with minimal impact on zzso oxygen zzso This paper, based on an expert consensus, aims to suggest criteria for the appropriate use of zzso agents in acute heart failure, based on a critical appraisal of the existing evidence and clinical zzso 

